交易中 04-01 10:43:24 美东时间
+0.940
+11.88%
agilon health shares are trading lower after the company announced a 1-for-25 r...
03-19 04:15
今日重点评级关注:HC Wainwright & Co.:维持NRX Pharmaceuticals"买入"评级,目标价从40美元升至45美元;RBC Capital:维持NUVATION BIO"跑赢大市"评级,目标价从12美元升至13美元
03-04 10:22
今日重点评级关注:巴克莱:维持C4 Therapeutics"超配"评级,目标价从5美元升至7美元;富国银行:维持Agilon Health"超配"评级,目标价从1美元升至1.5美元
03-02 14:08
Barclays analyst Andrew Mok maintains Agilon Health (NYSE:AGL) with a Underweight and lowers the price target from $1 to $0.5.
02-27 23:04
Agilon health shares are trading higher after the company reported better-than-...
02-27 00:58
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据agilon health业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** - 2025年第四季度营收15.7亿美元,全年营收59.3亿美元 - 营收受到低于预期的风险调整收入以及市场和付费方合同退出的影响 **利润率表现:** - 医疗利润率(Medical Margin):第四季度为负7400万美元,全年为负5700万美元 - 全年医疗利润率包括已退出市场的负6000万美元损失和前期发展的负5300万美元损失 **调整后EBITDA:** - 第四季度调整后EBITDA为负1.42亿美元 - 全年调整后EBITD
02-26 12:05
Agilon Health (NYSE:AGL) sees Q1 sales of $1.350 billion-$1.390 billion vs $1.586 billion analyst estimate.
02-26 06:51
Agilon Health (NYSE:AGL) reported its Q4 earnings results on Wednesday, Februar...
02-26 05:36
Gainers CASI Pharmaceuticals (NASDAQ:CASI) shares rose 54.2% to $0.32 during W...
02-26 05:07
Companies Reporting Before The Bell • Clear Secure (NYSE:YOU) is expected to re...
02-25 19:11